Byteflies

Name

Byteflies

Legal name

Byteflies NV

Website

https://byteflies.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Remote Patient Monitoring

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

akta.pro secondary industries

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO), Edge-Based Clinical Decision Support & Alerts (On-Device/On-Prem Analytics) (HLACAPAL), Neurology Telemedicine Platforms (HLALAGAC)

Keywords

• Remote patient monitoring
• Wearable medical devices
• Cardiac telemonitoring
• EEG monitoring systems
• Clinical trial telemetry

Headquarters

HQ city

Antwerp

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Remote Patient Monitoring - Pay-per-Use: Pay-per-use model where healthcare providers pay per patient monitored. No prior investment required. Covers device usage, data transmission, and basic reporting.
2. Data Annotation Services: Optional AI-powered and human-driven annotation services for ECG and EEG data analysis. Additional fee for detailed diagnostic insights and arrhythmia detection.
3. Clinical Trial Telemetry Services: Precision-driven data collection for clinical trials and real-world evidence studies. Serves life sciences and MedTech companies with compliant, high-quality patient vital signs data collection.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Byteflies provides medically-certified wearable telemonitoring solutions built around the Sensor Dot, a multi-purpose prescription medical device that captures biopotential (EEG, ECG, EMG) and motion data. The company delivers a suite of condition-specific monitoring "Flows" for cardiology, neurology/epilepsy, oncology, and COVID-19, bundled with AI analytics, human annotation services, device logistics, and EHR integration on a pay-per-use model. The platform enables healthcare providers and life sciences companies to obtain continuous, high-quality vital signs data from patients' homes without capital investment.

Product overview

Byteflies offers a modular telemonitoring platform built around the Sensor Dot wearable device and a suite of specialized monitoring Flows. The core architecture consists of medical-grade wearable hardware (Sensor Dot with disposable adhesive patches) combined with software platforms (Clinician Dashboard, optional data annotation services) and logistics management. The product portfolio is organized by therapeutic domain: Cardiology Flows (ECG Flow, 24h Flow, 24h Flow Non-Linear, Afib Flow, Plus Flow, Heart Failure Flow), Neurology/Epilepsy (EEG Flow, EpiCare@Home), and specialized applications (Covid Flow, Onco Flow). All flows operate on a pay-per-use model with end-to-end support including device logistics, stock management, and maintenance. The platform is medically certified (CE marked MDR, FDA 510(k) cleared, ISO 13485 compliant) and integrates with hospital EHR systems.

Differentiator

Problem solved

Functional benefit

Brands

• CardioCare@Home: Cardiac telemonitoring solution providing ECG monitoring, 24h monitoring, Afib monitoring, and heart failure monitoring for patients at home.
• Covid Flow
• EpiCare@Home
• Care@Home
• Sensor Dot
• Onco Flow

Products and services

• Sensor Dot Multi-purpose prescription wearable medical device that records biopotential (EEG, ECG, EMG) and inertial measurement unit (IMU) data. Cleared in EU (CE) and US (FDA 510(k)). Configurable with disposable adhesive patches for extended home monitoring.
• ECG Flow ECG-as-a-service offering precise raw 3-lead ECG data via the Sensor Dot while ensuring patient comfort during daily activities. Provides continuous cardiac rhythm recording with an easily exchangeable and rechargeable patch for extended monitoring with minimal lifestyle disruption.
• 24h Flow Hassle-free alternative to 24-hour Holter monitoring. Patients receive an accurate, comfortable multi-lead ECG patch with a pre-paid return envelope. After 24 hours, data is processed by AI and trained annotators, with high-quality insights delivered to the clinician dashboard.
• 24h Flow Non-Linear Advanced 24-hour ECG monitoring solution with enhanced lead placement using a triangular electrode configuration. Designed for more complex cases, offering comprehensive data and deeper diagnostic insights with higher P-wave clarity and improved diagnostic confidence.
• Afib Flow Continuous cardiac monitoring focused on atrial fibrillation detection and post-stroke/TIA care. Offers detailed annotations during critical post-insult days with prompt and precise care delivery when every moment counts.
• Plus Flow Enhanced ECG patch solution with comprehensive ECG annotation support for a wide range of arrhythmias. Adaptable for up to two weeks of monitoring with in-depth ECG analysis, minimal setup, and higher diagnostic yield for capturing significant cardiac events.
• Heart Failure Flow Customizable flow providing vital insights for heart failure patients including blood pressure, heart rate, body weight, body temperature, and activity. Enables rapid response, shorter hospital stays, and improved patient recovery.
• EEG Flow EEG-as-a-service for neurology applications, enabling insights in seizure burden or sleep quality from the patient's home. Collects raw EEG data that can be combined with ECG and motion data in a multimodal setup for improved sensitivity.
• EpiCare@Home Epilepsy monitoring solution combining medical wearable devices for low-montage EEG recording augmented with cardiorespiratory and motion data. Enables multi-day to multi-week seizure monitoring at home with human annotation services and clinical dashboard review.
• Covid Flow Home monitoring solution for COVID-19 patients including BioMeTs, patient app, healthcare provider dashboard, and telemonitoring team. Features NEWS2-based vital sign trending and integrates with hospital EMR systems for early deterioration detection.
• Onco Flow Cardio-oncology monitoring solution addressing cardiotoxicity risks from cancer treatments. Provides continuous remote monitoring features relevant during and after cancer treatment, including for new classes of immunotherapies.
• Data Annotation Services Human-driven annotation service where trained annotators review wearable device data and annotate potential seizure events shared with neurologists for final validation. Generates high-quality labeled data for algorithm development while enabling clinical use without increasing physician data review burden.
• 5G-CARE Telemonitoring solution with 5G connectivity and real-time data processing developed in partnership with Citymesh. Enables patients to be better monitored at home or on the go with improved connectivity.

Quantifiable outcome

• 3-4x faster cardiac monitoring process compared to traditional Holter, with comparable data quality and 93% patient positive clinical impact
• +4 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability9 records

Feature5 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• CitymeshcoreTechnology or IntegrationStrategic partnership for 5G-CARE project enabling telemonitoring with 5G connectivity. Patients can be better monitored at home or on the go with real-time data processing.
• nexuzhealthcoreStrategic or Co-development PartnerOncoCare@home project collaboration integrating telemetry with electronic patient records. Demonstrated significant benefits during COVID-19 pandemic.
• UCB PharmacoreStrategic or Co-development PartnerDigital health collaboration for epilepsy care innovation. UCB recognized value of EpiCare@Home and similar solutions for clinical trials and patient care.
• Epilepsy FoundationcoreStrategic or Co-development PartnerPartner organization for epilepsy awareness and advocacy. Hosts AEDD and Pipeline conferences bringing together technology enablers for epilepsy care.
• Thomas Jefferson UniversitycoreStrategic or Co-development PartnerOngoing prospective clinical trial (NCT05738226) at TJU focusing specifically on focal epilepsies using EpiCare@Home technology.
• Plug 'n Patch ConsortiumcoreStrategic or Co-development PartnerResearch consortium including academic and industrial partners awarded grant in 2019 to develop EEG patch designs with embedded biopotential electrodes.
• EIT Health (SeizeIT studies)coreStrategic or Co-development PartnerEU-funded research initiative supporting SeizeIT1 and SeizeIT2 studies for seizure detection algorithm development and clinical validation.
• Multiple Academic Medical CenterscoreStrategic or Co-development PartnerLong-standing collaborations with academic partners in EU and UK for data collection and algorithm validation across 600+ patients with 4,000+ seizures captured.
• Dr. Léopold LoumayeminorOthersCardiologist at private practice who successfully integrated Byteflies telemonitoring solution into clinical workflow and serves as key opinion leader.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• NeuroPace: NeuroPace's RNS System is a neurostimulation device for epilepsy that, like Byteflies' EpiCare@Home, addresses clinical decision-making for refractory epilepsy patients using chronic neural monitoring data.
• AliveCor: AliveCor's KardiaMobile and KardiaBand provide consumer- and clinician-facing single-lead ECG capture with AI-driven arrhythmia detection, competing with Byteflies' ECG Flow in cardiology and arrhythmia screening use cases.
• Empatica: Empatica's EpiMonitor and Embrace are FDA-cleared wearable devices for seizure detection and continuous multimodal monitoring, directly comparable to Byteflies' EpiCare@Home epilepsy monitoring solution.
• Compumedics: Compumedics manufactures EEG, sleep, and long-term monitoring systems with cloud and ambulatory capabilities, overlapping with Byteflies' EEG Flow and EpiCare@Home neurology offerings.
• iRhythm Technologies: iRhythm's Zio patch is a direct competitor to Byteflies' ECG/24h Flow products, providing ambulatory cardiac monitoring with proprietary AI arrhythmia detection and a similar pay-per-use service model targeting hospitals and clinicians.
• Current Health (Best Buy Health): Current Health provides a remote patient monitoring platform with wearable biosensors, vital-sign capture, and EHR integration — directly comparable to Byteflies' continuous vitals monitoring across multiple therapeutic areas.
• Preventice Solutions (Boston Scientific): BodyGuardian remote cardiac monitoring solutions target the same ambulatory cardiology market as Byteflies' CardioCare@Home, including Holter, event, and mobile cardiac telemetry services for hospitals.
• Huma Therapeutics: Huma provides a remote patient monitoring platform for hospitals, combining wearable vitals capture with clinician dashboards — comparable to Byteflies' software-platform layer spanning cardiology, oncology, and general monitoring.

Broad incumbents

• Medtronic: Medtronic's LINQ insertable cardiac monitor and broader diagnostics portfolio compete with Byteflies in cardiac ambulatory monitoring and remote patient monitoring for cardiology departments.
• BioTel (Philips): Philips BioTel Heart provides ambulatory cardiac monitoring services (MCOT) comparable to Byteflies' ECG/24h Flow, embedded within a much larger portfolio of connected hospital technologies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/byteflies
• Facebookfacebook.com/byteflies

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Byteflies